ConductScience.org, home

Library / Trials

Attentional Focus Training in Older Adults

NCT06700928, Not applicable, Completed, Müşerref Ebru YALÇIN

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleAttentional Focus Training in Older AdultsClinicalTrials.gov
NCT numberNCT06700928ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment50 participants, actualClinicalTrials.gov
Lead sponsorMüşerref Ebru YALÇINClinicalTrials.gov
ConditionsGeriatric Individuals, Cognitive Function, Physical PerformanceClinicalTrials.gov
InterventionsExternal focus training, Internal focus training, No attentional focus trainingClinicalTrials.gov
First posted2024-11-22ClinicalTrials.gov
Last updated2026-04-07ClinicalTrials.gov

Registered outcomes 3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryThe Short Physical Performance Battery (SPPB), stair climbing test, Timed Up and Go (TUG) test, Berg balance test, and single leg stance test12 weeksThe Short Physical Performance Battery (SPPB), stair climbing test, Timed Up and Go (TUG) test, Berg balance test, and single leg stance test will be used to assess physical performance.ClinicalTrials.gov
PrimaryCentral Nervous System Vital Signs (CNSVS)12 weeks
The "Central Nervous System Vital Signs (CNSVS) Cognitive Performance and Attention Tests" will be administered to assess cognitive functions. CNSVS is an evaluation tool designed to examine the neurocognitive status of individuals aged 7 to 90. It consists of several subtests, including the Verbal Memory Test, Visual Memory Test, Finger Tapping Test, Symbol-Digit Coding Test, Stroop Test, Continuous Performance Test, and Attention Switching Test. In our study, scores obtained from these subtests will be utilized. To determine the extent of neurocognitive impairment, classification is made based on standard score points. According to this classification: \>110 indicates high capacity, 90-110 indicates normal capacity, 80-89 indicates mild cognitive impairment, 70-79 indicates moderate cognitive impairment, and \<70 indicates severe cognitive impairment.
ClinicalTrials.gov
SecondaryGait analysis using Kinect V212 weeks
The gait analysis of participants will be conducted using Kinect V2 camera-based software. This software is developed in the MATLAB environment and processes depth images to identify joint positions. It determines the corresponding joint position for each pixel in the depth image and calculates the accuracy of this position. This enables the detection and accuracy assessment of joint positions. Parameters such as gait symmetry, step length, step width, cadence, and speed will be evaluated.
ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 3

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Continuous Performance TestPrimary outcomeConductCognition
Finger Tapping TaskPrimary outcomeConductCognition
Stroop Color-Word TestPrimary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)